Dermapharm Holding SE
Dermapharm Holding SE (DMPHF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · DMPHF · as of Jun 8, 2026
Key Statistics
Explore Dermapharm Holding SE Data
dmphf stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
dmphf competitorsDMPHF
ARSUF
BRCTF
CASBF
CHSYF
CURLFStock Performance
Full HistoryAbout Dermapharm Holding SE
Dermapharm Holding SE is an international pharmaceutical company specializing in off-patent branded medications, serving both domestic and global markets. Its business is structured across three disti…
what is dermapharm holding se · dmphf stock overview · dermapharm holding se company profile · who is dermapharm holding se ceo · dmphf OTC · dermapharm holding se headquarters · dermapharm holding se business segments
About Stock Overview & Key Data
Dermapharm Holding SE (DMPHF) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on OTC since Nov 29, 2022. As of the latest trading session, DMPHF stock price is $59.00, with a market capitalization of $2.9B. The stock has returned +49.14% over the past 12 months and +49.14% year-to-date.
In fiscal year 2025, Dermapharm Holding SE reported revenue of $1.2B. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Dermapharm Holding SE (DMPHF) stock price is $59.00. The stock is traded on OTC under the ticker symbol DMPHF. The 52-week range is $39.56 – $59.00.